Owkin to Integrate Kognitic's Clinical Trial Data Into K Pro Through New Collaboration
NEW YORK & PARIS — Owkin, the agentic AI company pioneering Biological Artificial SuperIntelligence to revolutionize drug discovery and development, today announced a data collaboration with Kognitic to integrate Kognitic's clinical trial data into K Pro, Owkin's AI Scientist. The collaboration will initially focus on oncology and immunology, with the potential to expand into additional therapeutic areas and datasets over time.
Kognitic structures global clinical trial signals into a normalized, decision-ready evidence layer for commercial, medical, and BD teams. These signals span trial registries, pipeline timelines, and competitive landscape data. Through this collaboration, Kognitic clinical data will be accessible directly within K Pro, giving decision-making teams a single source of data across fragmented feeds.
K Pro combines multimodal patient data with specialized biological, agentic AI systems to support each stage of the pharmaceutical value chain. Bringing Kognitic's clinical trial data into that layer extends K Pro's reach into competitive intelligence and portfolio-decision use cases, alongside its existing biological and multimodal data capabilities.
Thomas Clozel, MD, Co-founder and CEO, Owkin:
Pharmaceutical decision-making depends on the best, structured, real-time data. Bringing Kognitic’s clinical trial data into K Pro gives our partners a faster, more complete picture the moment they need it.
Kimon Lounis, Director of Commercial Strategy & Partnerships, Kognitic:
This partnership is a major milestone for Kognitic and for how clinical trial data can power advanced AI in life sciences. By bringing Kognitic’s clinical trial data into K Pro, we can support Owkin’s AI Scientist with richer evidence for agentic workflows and biological reasoning.
Jaseem Mahmmdla, Co-Founder and CEO, Kognitic:
The next generation of AI in life sciences will be built through partnerships that combine best-in-class intelligence. Owkin has built an exceptional platform with K Pro, and together we’re bringing trusted clinical trial data into a unified environment to help pharmaceutical teams make faster, more informed decisions.
About Owkin
Owkin is an agentic AI company pioneering Biological Artificial Superintelligence to solve problems in biology where human researchers alone have failed.
Owkin builds K Pro - an AI scientist for pharmaceutical research and strategic decision-making. K Pro orchestrates a suite of AI skills and tools to decode complex biology, accelerate research, and dramatically increase productivity.
K Pro is built on Owkin’s unrivalled multimodal patient data network, state-of-the-art AI for biology and a decade of experience working with pharmaceutical partners.
